Automated cell manufacturing company Mytos has partnered with Aspen Neuroscience to automate the production of customized cells for Aspen’s Parkinson’s disease therapy. Under the agreement, Aspen will use Mytos’s iDEM technology to manage cell production in its California-based factory. The deal allows Aspen to streamline its cell production process, reducing labor and enabling multibatch handling to increase capacity. A manual iDEM alternative can be learned by a single operator.
Warning issued over ‘fast flux’ techniques used to obscure malicious signals on compromised networks
Law enforcement agencies have warned that organizations face a common network vulnerability that allows hackers to dodge detection and distribute malicious software indiscriminately. Referred to
